Levin Capital Strategies, L.P. Acquires 27,100 Shares of Fluidigm Co. (NASDAQ:FLDM) Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 27,100 shares of the company’s stock in a transaction that occurred on Wednesday, December 27th. The shares were purchased at an average price of $5.88 per share, with a total value of $159,348.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, January 10th, Levin Capital Strategies, L.P. acquired 100,576 shares of Fluidigm stock. The shares were bought at an average cost of $6.34 per share, for a total transaction of $637,651.84.
  • On Wednesday, January 3rd, Levin Capital Strategies, L.P. acquired 29 shares of Fluidigm stock. The shares were bought at an average cost of $6.63 per share, for a total transaction of $192.27.
  • On Friday, December 28th, Levin Capital Strategies, L.P. acquired 30 shares of Fluidigm stock. The shares were bought at an average cost of $5.82 per share, for a total transaction of $174.60.
  • On Friday, December 29th, Levin Capital Strategies, L.P. acquired 11,230 shares of Fluidigm stock. The shares were bought at an average cost of $5.94 per share, for a total transaction of $66,706.20.
  • On Friday, December 15th, Levin Capital Strategies, L.P. acquired 24,175 shares of Fluidigm stock. The shares were bought at an average cost of $5.84 per share, for a total transaction of $141,182.00.
  • On Tuesday, December 12th, Levin Capital Strategies, L.P. acquired 18,569 shares of Fluidigm stock. The shares were bought at an average cost of $5.84 per share, for a total transaction of $108,442.96.
  • On Monday, December 4th, Levin Capital Strategies, L.P. acquired 8,409 shares of Fluidigm stock. The shares were bought at an average cost of $5.48 per share, for a total transaction of $46,081.32.
  • On Wednesday, November 29th, Levin Capital Strategies, L.P. acquired 20,380 shares of Fluidigm stock. The shares were bought at an average cost of $5.71 per share, for a total transaction of $116,369.80.
  • On Friday, November 17th, Levin Capital Strategies, L.P. acquired 6,880 shares of Fluidigm stock. The shares were bought at an average cost of $5.05 per share, for a total transaction of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. acquired 54,900 shares of Fluidigm stock. The shares were bought at an average cost of $5.26 per share, for a total transaction of $288,774.00.

Fluidigm Co. (FLDM) opened at $6.59 on Friday. Fluidigm Co. has a 12 month low of $2.52 and a 12 month high of $8.04. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02.

Institutional investors have recently made changes to their positions in the company. Sei Investments Co. lifted its stake in shares of Fluidigm by 221.7% in the 3rd quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 14,932 shares during the last quarter. Group One Trading L.P. lifted its stake in shares of Fluidigm by 336.9% in the 3rd quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 17,855 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Fluidigm in the 3rd quarter valued at $123,000. Virtu KCG Holdings LLC acquired a new position in shares of Fluidigm in the 2nd quarter valued at $105,000. Finally, PDT Partners LLC lifted its stake in shares of Fluidigm by 56.0% in the 2nd quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 9,800 shares during the last quarter. 93.27% of the stock is currently owned by institutional investors and hedge funds.

Separately, ValuEngine raised Fluidigm from a “strong sell” rating to a “sell” rating in a research note on Monday, October 23rd.

ILLEGAL ACTIVITY WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/13/fluidigm-co-fldm-insider-levin-capital-strategies-l-p-buys-27100-shares.html.

About Fluidigm

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply